Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has shared an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has scheduled a board meeting for March 13, 2025, to review and approve the audited financial results for the year ending December 31, 2024. This meeting will be crucial for stakeholders as it will provide insights into the company’s financial health and operational performance over the past year.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is based in Guangzhou, China, and is involved in a range of healthcare-related services and products.
YTD Price Performance: 2.40%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.67B
For an in-depth examination of 0874 stock, go to TipRanks’ Stock Analysis page.